This study demonstrates that alginate-based antireflux medications inhibit E-cadherin proteolysis, a phenomenon observed in GERD and LPR biopsies which is sufficient to cause barrier dysfunction. This evidence concerns the gene CDH1 and gastroesophageal reflux disease.